Personalized Psychiatry 2020
DOI: 10.1016/b978-0-12-813176-3.00012-2
|View full text |Cite
|
Sign up to set email alerts
|

Personalized psychiatry with human iPSCs and neuronal reprogramming

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 188 publications
0
4
0
Order By: Relevance
“…Finally, we should point out that recent progress in human-induced pluripotent stem cell (iPSC) technologies provide excellent novel platforms for modeling the genetic mechanisms underlying MDD [118]. These models could be useful especially for studying individual differences and for developing personalized therapies [119]. Furthermore, single-cell models allow the quantitative analysis of synaptic transmission and the plasticity of different cell lines (i.e., GABA-or glutamatergic neurons) and these models are also valuable for compound screening [120].…”
Section: Hippocampal Formationmentioning
confidence: 99%
“…Finally, we should point out that recent progress in human-induced pluripotent stem cell (iPSC) technologies provide excellent novel platforms for modeling the genetic mechanisms underlying MDD [118]. These models could be useful especially for studying individual differences and for developing personalized therapies [119]. Furthermore, single-cell models allow the quantitative analysis of synaptic transmission and the plasticity of different cell lines (i.e., GABA-or glutamatergic neurons) and these models are also valuable for compound screening [120].…”
Section: Hippocampal Formationmentioning
confidence: 99%
“…Patient-derived iPSCs are increasingly popular pre-clinical models of neurological and psychiatric disorders ( Bardy et al., 2020 ; Chailangkarn et al., 2016 ; Israel et al., 2012 ; Mertens et al., 2016 ; Sarkar et al., 2018 ; Tran et al., 2020 ; van den Hurk and Bardy, 2019 ). Two-dimensional monolayer models offer reproducible and relatively high-throughput drug screening capabilities.…”
Section: Discussionmentioning
confidence: 99%
“…We suggest using brains from animals like nonhuman primates or infertile cattle with an extra X chromosome [ 10 ] or neuronal tissue generated using human induced pluripotent stem cells, preferably from women with TXS and differences in the psychiatric phenotype. The use of human induced pluripotent stem cells harbors the promise of discovering new treatment options for neuropsychiatric disorders [ 47 ].…”
Section: Discussionmentioning
confidence: 99%